Diferenciación epitelial in vitro de células mesenquimales troncales humanas (hCMTs) de tejido adiposo (TA) y médula ósea (MO): caracterización celular y estudio de expresión de HLA I y II

  1. Sierra-Sánchez, Álvaro 1
  2. Ruíz-García, Antonio 1
  3. Guerrero Calvo, Jorge 1
  4. Fernández Porcel, Natividad 1
  5. Espinosa Ibáñez, Olga 1
  6. Lizana Moreno, Antonio Manuel 1
  7. Fernández González, Ana 1
  8. Aneiros-Fernández, José 1
  9. Arias-Santiago, Salvador 1
  1. 1 Universidad de Granada
    info

    Universidad de Granada

    Granada, España

    ROR https://ror.org/04njjy449

Revista:
Actualidad médica

ISSN: 0365-7965

Ano de publicación: 2016

Tomo: 101

Número: 798

Páxinas: 72-78

Tipo: Artigo

DOI: 10.15568/AM.2016.798.OR02 DIALNET GOOGLE SCHOLAR lock_openAcceso aberto editor

Outras publicacións en: Actualidad médica

Resumo

Background: Human mesenchymal stem cells derived from adipose tissue and bone marrow are one of the most common cell therapy procedures used in recent clinical trials due to their immunomodulation capacity. Furthermore, for their epithelial differentiation potential can be used in tissue engineering, incorporated in artificial tissues such as skin and cornea, replacing autologous epithelial cells. It is necessary to make a correct cellular characterization of differentiated cells and to study the effect in HLA I and II expression. Objetives: Characterization and quality controls under GMP conditions of in vitro differentiated human mesenchymal stem cells from different sources (adipose tissue and bone marrow) to epithelial lineage, and study of HLA I and II expression before and after differentiation. Methods: Isolation and expansion of two human mesenchymal stem cells lines from their tissues of origin and in vitro differentiation to epithelial cells using culture mediums supplemented with specific growth factors. Quality controls according Good Manufacturing Practices have been made and HLA I and II expression before and after differentiation have been studied. Finally, characteristics of differentiated cells have been demonstrated by histological and immunohistochemical analysis. Results: Two human mesenchymal stem cells lines from adipose tissue and bone marrow have been isolated complying with the proposed quality controls. After in vitro differentiation, human mesenchymal stem cells do not express HLA (I and II) markers, which are important in immune response, but weakly express proteins related to main epithelial layers of human skin (CK5, CK6 and CK14). Conclusion: The absence of expression of HLA I and II by flow cytometry in differentiated cells would promote the use of them with allogenic character to construct human skin and cornea by tissue engineering, however, more studies and protocols are required to confirm these preliminary results and to optimize in vitro differentiation of human mesenchymal stem cells.

Referencias bibliográficas

  • Abumaree MH, Abomaray FM, Alshehri NA, Almutairi A, AlAskar AS, Kalionis B, et al. Phenotypic and Functional Characterization of Mesenchymal Stem/Multipotent Stromal Cells From Decidua Parietalis of Human Term Placenta. Reprod Sci. 2016; Available from: http://www.ncbi.nlm.nih. gov/pubmed/26902429
  • Abumaree MH, Al Jumah MA, Kalionis B, Jawdat D, Al Khaldi A, AlTalabani AA, et al. Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta. Stem Cell Rev. 2013;9(1):16–31.
  • Atala A. Regenerative medicine strategies. J Pediatr Surg. 2012;47:17–28.
  • Chavez-Munoz C, Nguyen KT, Xu W, Hong S-J, Mustoe TA, Galiano RD. Transdifferentiation of adipose-derived stem cells into keratinocyte-like cells: engineering a stratified epidermis. PLoS One. 2013;8(12):e80587.
  • Dauleh S, Santeramo I, Fielding 1¤ C, Ward K, Herrmann A, Murray P, et al. Characterisation of Cultured Mesothelial Cells Derived from the Murine Adult Omentum. PLoS One. 2016;11 (7).
  • Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy.2006;8(4):315–7.
  • Fisher MB, Mauck RL. Tissue engineering and regenerative medicine: recent innovations and the transition to translation. Tissue Eng Part B Rev. 2013;19(1):1–13.
  • Gao Z-W, Dong K, Zhang H-Z. The Roles of CD73 in Cancer. Biomed Res Int. 2014;2014.
  • Garzón I, Martín-Piedra MA, Alfonso-Rodríguez C, GonzálezAndrades M, Carriel V, Martínez-Gómez C, et al. Generation of a biomimetic human artificial cornea model using Wharton’s jelly mesenchymal stem cells. Invest Ophthalmol Vis Sci. 2014;55(7):4073–83.
  • Garzón I, Miyake J, González-Andrades M, Carmona R, Carda C, Sánchez-Quevedo M del C, et al. Wharton’s jelly stem cells: a novel cell source for oral mucosa and skin epithelia regeneration. Stem Cells Transl Med. 2013;2(8):625–32.
  • Heslop JA, Hammond TG, Santeramo I, Tort Piella A, Hopp I, Zhou J, et al. Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies. Stem Cells Transl Med. 2015;4(4):389–400.
  • L Ramos T, Sánchez-Abarca LI, Muntión S, Preciado S, Puig N, López-Ruano G, et al. MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry. Cell Commun Signal. 2016;14:2.
  • Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31(10):890–6.
  • Llames SG, Del Rio M, Larcher F, García E, García M, Escamez MJ, et al. Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin. Transplantation. 2004;77(3):350–5.
  • Long EO, Jacobson S. Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry? Immunol Today. 1989;10(2):45–8.
  • Maleki M, Ghanbarvand F, Behvarz MR, Ejtemaei M, Ghadirkhomi E. Comparison of Mesenchymal Stem Cell Markers in Multiple Human Adult Stem Cells. Int J Stem Cells. 2014;7(2).
  • Mao AS, Mooney DJ. Regenerative medicine: Current therapies and future directions. Proc Natl Acad Sci U S A. 2015;112(47):14452–9.
  • Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol. Springer; 2008;129(6):705–33.
  • Nassiri F, Cusimano MD, Scheithauer BW, Rotondo F, Fazio A, Yousef GM, et al. Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res. 2011;31(6):2283–90.
  • Pérez-Sala D, Oeste CL, Martínez AE, Carrasco MJ, Garzón B, Cañada FJ. Vimentin filament organization and stress sensing depend on its single cysteine residue and zinc binding. Nat Commun. 2015;6:7287.
  • Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science.1999;284(5411):143–7.
  • Shin K-S, Na K-H, Lee H-J, Kim D-G, Shin S-J, Kim JK, et al. Characterization of Fetal Tissue-derived Mesenchymal Stem Cells. Int J stem cells. 2009;2(1):51–8.
  • Shokrgozar MA, Fattahi M, Bonakdar S, Ragerdi Kashani I, Majidi M, Haghighipour N, et al. Healing potential of mesenchymal stem cells cultured on a collagen-based scaffold for skin regeneration. Iran Biomed J. 2012;16(2):68–76.
  • Stern LJ, Wiley DC. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure. 1994;2:245–51.
  • Stoltz J-F, De Isla N, Li YP, Bensoussan D, Zhang L, Huselstein C, et al. Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century. Stem Cells Int. 2015;2015.
  • SundarRaj N, Rizzo JD, Anderson SC, Gesiotto JP. Expression of vimentin by rabbit corneal epithelial cells during wound repair. Cell Tissue Res. 1992;267(2):347–56.
  • Technau A, Froelich K, Hagen R, Kleinsasser N. Adipose tissue-derived stem cells show both immunogenic and immunosuppressive properties after chondrogenic differentiation. Cytotherapy. 2011;13(3):310–7.
  • Trivedi VB, Dave AP, Dave JM, Patel BC. Human Leukocyte Antigen and Its Role in Transplantation Biology. Transplant Proc. 2007;39(3):688–93.
  • Tsukamoto A, Abbot SE, Kadyk LC, DeWitt ND, Schaffer D V., Wertheim JA, et al. Challenging Regeneration to Transform Medicine. Stem Cells Transl Med. 2016;5(1):1–7.
  • Witten CM, McFarland RD, Simek SL. Concise Review: The U.S. Food and Drug Administration and Regenerative Medicine. Stem Cells Transl Med. 2015;4(12):1495–9.
Fonte de datos: Dialnet